title: Underestimating cardiac toxicity in cancer trials: lessons learned?
authors.forename: Ronald M
authors.initials: RM
authors.lastname: Witteles
authors.forename: Melinda
authors.initials: M
authors.lastname: Telli
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000592:standards; D004348:Drug Labeling; D016903:Drug Monitoring / Q000379:methods* / Q000592:standards; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*; D011758:Pyrroles / Q000009:adverse effects*; D013318:Stroke Volume / Q000187:drug effects; D000077210:Sunitinib; D018487:Ventricular Dysfunction, Left / Q000139:chemically induced
chemical_list: D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib